P&G stock price slips as Fed week begins, after analyst upgrades flagged a second-half lift
26 January 2026
2 mins read

P&G stock price slips as Fed week begins, after analyst upgrades flagged a second-half lift

NEW YORK, Jan 26, 2026, 12:09 EST — Regular session

  • Procter & Gamble shares dipped slightly around midday, trailing behind a broader uptick on Wall Street.
  • After P&G maintained its full-year outlook and signaled gains in the second half, analysts boosted their price targets.
  • The Fed’s decision on Jan. 28 is the next major macro event, with the spotlight on interest rates and consumer demand.

Procter & Gamble shares dipped Monday, with PG falling roughly 0.7% to $149.11 by midday. The stock traded within a narrow band, bouncing between $149.07 and $150.83 during the session.

U.S. stocks gained ground ahead of a packed week featuring mega-cap tech earnings and a Federal Reserve policy announcement. At the same time, gold hit record highs as safe-haven buying ramped up. 1

P&G often serves as a defensive pick for funds. Investors flock to staples when growth falters — that is, until bond yields rise and shift the calculations.

Consumer staples showed some weakness today. The Consumer Staples Select Sector SPDR Fund (XLP) slipped around 0.2%. Colgate-Palmolive dropped about 1.2%, Kimberly-Clark edged down roughly 0.3%, and Church & Dwight remained mostly flat.

Late last week brought a wave of bullish notes, pushing P&G into the spotlight this Monday. JPMorgan upgraded the stock to Overweight and boosted its price target to $165. Analyst Andrea Teixeira described the company as “poised to accelerate organic sales growth.” On the recent earnings call, CFO Andre Schulten emphasized management’s “objective to leave the year with share growth.” 2

Wells Fargo raised its price target to $165, describing the quarter as meeting “a low bar” but leaving room for “better prospects in the second half.” The bank highlighted steady international trends, though it singled out the U.S. consumer environment as the key variable. 3

P&G reported second-quarter net sales up 1% to $22.2 billion, with organic sales flat and core earnings per share steady at $1.88. Organic sales strip out currency effects, acquisitions, and divestitures to highlight underlying demand. The company maintained its full-year core EPS forecast at $6.83 to $7.09. Tariff costs are now expected to total about $400 million after tax. CEO Shailesh Jejurikar said the results “keep us on track” amid a “challenging consumer and geopolitical environment.” 4

After the earnings release, P&G submitted its quarterly 10-Q along with supplemental materials related to the call. Investors typically dig through these filings for insights on category volumes, margin challenges, and restructuring costs. 5

The tug-of-war is familiar: P&G can hold margins through pricing and product mix, but only so far. When shoppers hunt for bargains or shift to cheaper options, volume beats price every time.

The recent update pointed to softer U.S. spending in key categories, with volumes down across most of P&G’s product lines. Tariffs and a shift toward smaller, cheaper packs are squeezing margins, tightening the cushion if demand weakens again. 6

The Fed’s Jan. 27-28 meeting is looming, with the rate decision set for Jan. 28 — a key event that could shake up valuations in the market’s defensive sectors. Traders are also keeping an eye on this week’s data for clues about whether the U.S. consumer will hold steady through spring, especially for P&G. 7

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Applied Materials stock slips midday as chip-equipment trade turns cautious ahead of ASML results
Previous Story

Applied Materials stock slips midday as chip-equipment trade turns cautious ahead of ASML results

CoreWeave stock jumps nearly 10% after Nvidia’s $2 billion buy-in puts CRWV back in focus
Next Story

CoreWeave stock jumps nearly 10% after Nvidia’s $2 billion buy-in puts CRWV back in focus

Go toTop